These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26553766)

  • 1. Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival.
    Movva S; von Mehren M; Ross EA; Handorf E
    J Natl Compr Canc Netw; 2015 Nov; 13(11):1366-74. PubMed ID: 26553766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.
    Miura JT; Charlson J; Gamblin TC; Eastwood D; Banerjee A; Johnston FM; Turaga KK
    Eur J Surg Oncol; 2015 Oct; 41(10):1386-92. PubMed ID: 26251340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma.
    Yu PY; Beal EW; Hughes TM; Suarez-Kelly LP; Shelby RD; Ethun CG; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
    J Surg Res; 2018 Nov; 231():248-256. PubMed ID: 30278937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity.
    Vlenterie M; Litière S; Rizzo E; Marréaud S; Judson I; Gelderblom H; Le Cesne A; Wardelmann E; Messiou C; Gronchi A; van der Graaf WT
    Eur J Cancer; 2016 May; 58():62-72. PubMed ID: 26968015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative.
    Zaidi MY; Ethun CG; Tran TB; Poultsides G; Grignol VP; Howard JH; Bedi M; Mogal H; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick B; Fields RC; Oskouei S; Reimer N; Monson D; Maithel SK; Cardona K
    Ann Surg Oncol; 2019 Oct; 26(11):3542-3549. PubMed ID: 31342400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study.
    Young RJ; Litière S; Lia M; Hogendoorn PCW; Fisher C; Mechtersheimer G; Daugaard S; Sciot R; Collin F; Messiou C; Grünwald V; Gronchi A; van der Graaf W; Wardelmann E; Judson I
    Acta Oncol; 2017 Jul; 56(7):1013-1020. PubMed ID: 28431480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
    Jain V; Venigalla S; Sebro RA; Karakousis GC; Wilson RJ; Weber KL; Shabason JE
    Cancer Med; 2019 Oct; 8(14):6295-6304. PubMed ID: 31483578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Ifosfamide-doxorubicin chemotherapy in histology-specific, high grade, locally advanced soft tissue sarcoma, a 14-year experience.
    Goy BW; Syed S; Padmanabhan A; Burchette RJ; Helmstedter CS
    Radiother Oncol; 2021 Dec; 165():174-178. PubMed ID: 34758339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization pattern and survival outcomes of adjuvant therapies in high-grade nonretroperitoneal abdominal soft tissue sarcoma: A population-based study.
    Green WR; Chokshi R; Jabbour SK; DeLaney TF; Mahmoud O
    Asia Pac J Clin Oncol; 2018 Feb; 14(1):101-113. PubMed ID: 28464497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Interval Between Preoperative Radiation and Surgery Is Not Associated with Overall Survival for Soft-tissue Sarcomas: An Analysis of the National Cancer Database.
    Collier CD; Kim CY; Liu RW; Getty PJ
    Clin Orthop Relat Res; 2021 Mar; 479(3):506-517. PubMed ID: 32401002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG.
    Grünwald V; Litière S; Young R; Messiou C; Lia M; Wardelmann E; van der Graaf W; Gronchi A; Judson I;
    Eur J Cancer; 2016 Sep; 64():44-51. PubMed ID: 27323349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials.
    Young RJ; Natukunda A; Litière S; Woll PJ; Wardelmann E; van der Graaf WT
    Eur J Cancer; 2014 Dec; 50(18):3178-86. PubMed ID: 25459395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the addition of chemotherapy to neoadjuvant radiotherapy impact survival in high-risk extremity/trunk soft-tissue sarcoma?
    Chowdhary M; Chowdhary A; Sen N; Zaorsky NG; Patel KR; Wang D
    Cancer; 2019 Nov; 125(21):3801-3809. PubMed ID: 31490546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma.
    Greto D; Saieva C; Loi M; Desideri I; Delli Paoli C; Lo Russo M; Pezzulla D; Teriaca MA; Lucidi S; Visani L; Terziani F; Olmetto E; Becherini C; Bonomo P; Francolini G; Campanacci DA; Scoccianti G; Livi L
    Am J Clin Oncol; 2019 Oct; 42(10):749-754. PubMed ID: 31503061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base.
    Asare EA; Compton CC; Hanna NN; Kosinski LA; Washington MK; Kakar S; Weiser MR; Overman MJ
    Cancer; 2016 Jan; 122(2):213-21. PubMed ID: 26506400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limb-sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high-grade, extremity soft-tissue sarcoma from the NCDB and SEER.
    Ramey SJ; Yechieli R; Zhao W; Kodiyan J; Asher D; Chinea FM; Patel V; Reis IM; Wang L; Wilky BA; Subhawong T; Trent JC
    Cancer Med; 2018 Sep; 7(9):4228-4239. PubMed ID: 30030882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
    Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
    Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database.
    Ethun CG; Lopez-Aguiar AG; Switchenko JM; Gillespie TW; Delman KA; Staley CA; Maithel SK; Cardona K
    Ann Surg Oncol; 2019 Dec; 26(13):4723-4729. PubMed ID: 31502023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
    Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
    Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups.
    Gronchi A; Palmerini E; Quagliuolo V; Martin Broto J; Lopez Pousa A; Grignani G; Brunello A; Blay JY; Tendero O; Diaz Beveridge R; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Braglia L; Donati DM; Palassini E; Bianchi G; Marrari A; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
    J Clin Oncol; 2020 Jul; 38(19):2178-2186. PubMed ID: 32421444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.